The metabolites in the tryptophan degradation pathway might be useful to determine the tolerable upper intake level of tryptophan intake in rats

Journal of Nutrition

Volumn 142, Issue 12, 2012, Pages

  Shibata, Katsumi ^a   Fukuwatari, Tsutomu ^a  

^a UNIVERSITY OF SHIGA PREFECTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRANILIC ACID; KYNURENIC ACID; TRYPTOPHAN;

ARTICLE; BODY WEIGHT; DIET SUPPLEMENTATION; HUMAN; NONHUMAN; NUTRITIONAL STATUS; PREDICTOR VARIABLE; PROTEIN DEGRADATION; PROTEIN INTAKE; PROTEIN METABOLISM; RAT; URINARY EXCRETION;

ADULT; ANIMALS; FEMALE; HUMANS; KYNURENIC ACID; MALE; NIACINAMIDE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; NUTRITIONAL REQUIREMENTS; ORTHO-AMINOBENZOATES; RATS; RATS, WISTAR; TRYPTOPHAN; VITAMINS;

RATTUS;

EID: 84872153596     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.163469     Document Type: Article

References (35)

1. Uchiyama M. Progress report of the studies in Japan on eosinophiliamyalgia syndrome caused by L-tryptophan product. Shokuhin Eiseigaku Zasshi. 1999;40:335-55.
2. Maitani T, Saitoh H. Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil -20 years after outbreak of EMS- Shokuhin Eiseigaku Zasshi. 2009;50:279-91.
3. Ministry of Health, Labor, and Welfare of Japan. Dietary reference intakes for Japanese, 2010. Tokyo: Ministry of Health, Labor, and Welfare of Japan; 2009.
4. Okuno A, Fukuwatari T, Shibata K. Urinary excretory ratio of anthranilic acid/kynurenic acid as an index of the tolerable amount of tryptophan. Biosci Biotechnol Biochem. 2008;72:1667-72.
5. Fukuwatari T, Ohta M, Kimura N, Sasaki R, Shibata K. Conversion ratio of tryptophan to niacin in Japanese women fed a purified diet conforming to the Japanese dietary reference intakes. J Nutr Sci Vitaminol (Tokyo). 2004;50:385-91.
6. Fukuwatari T, Ohta M, Sugimoto E, Sasaki R, Shibata K. Effects of dietary di(2-ethylhexul)phthalate, a putative endocrine disrupter, on enzyme activities involved in the metabolism of tryptophan to niacin in rats. Biochim Biophys Acta. 2004;1672:67-75.
7. Hajak G, Huether G, Blanke J, Blömer M, Freyer C, Poeggeler B, Reimer A, Rodenbeck A, Schulz-Varszegi M, Rüther E. The influence of intravenous L-tryptophan on plasma melatonin and sleep in men. Pharmacopsychiatry. 1991;24:17-20.
8. Ouichou A, Pévet P. Implication of tryptophan in the stimulatory effect of delta-sleep-inducing peptide on indole secretion form perfused rat pineal glands. Biol Signals. 1992;1:78-87.
9. Shibata K. Relationship between the ratio of the excreted by-products of niacin metabolism, N1-methyl-2-pyridone-5-carboxamide+N1-methyl-3- pyridone-4-carboxamide/N1-methylnicotinamide and amino acid intake. Vitamins (Japan). 1990;64:1-18.
10. Shibata K. Effect of protein-amino acids, lipid, and carbohydrate on the conversion ratio of tryptophan to niacin. Vitamins (Japan). 1996;70: 369-82.
11. Fukuwatari T, Wada H, Sasaki R, Shibata K. Effect of excess nicotinamide administration on the urinary excretion of nicotinamide N-oxide and nicotinic acid by rats. Biosci Biotechnol Biochem. 2004; 68:44-50.
12. Nishizuka Y, Hayaishi O. Studies on the biosynthesis of nicotinamide adenine dinucleotide. I. Enzymic synthesis of niacin ribonucleotides from 3-hydroxyanthranilic acid in mammalian tissues. J Biol Chem. 1963;238:3369-77.
13. Shibata K. Conversion ratio of tryptophan to niacin in rats fed with a nicotinic acid-free, tryptophan-limiting diet. Biosci Biotechnol Biochem. 1995;59:715-6.
14. Shibata K, Mushiage M, Kondo T, Hayakawa T, Tsuge H. Effect of vitamin B6 deficiency on the conversion ratio of tryptophan to niacin. Biosci Biotechnol Biochem. 1995;59:2060-3.
15. Shibata K, Shimada H, Kondo T. Effects of feeding tryptophan-limiting diets on the conversion ratio of tryptophan to niacin in rats. Biosci Biotechnol Biochem. 1996;60:1660-6.
16. Shibata K, Kondo T. Effect of progesterone and estrone on the conversion of tryptophan to nicotinamide in rats. Biosci Biotechnol Biochem. 1993; 57:1890-3.
17. Shibata K, Toda S. Effect of thyroxine on the metabolism of tryptophan to nicotinamide in rats. Biosci Biotechnol Biochem. 1994;58:1757-62.
18. Shibata K. Effect of adrenalin on the conversion ratio of tryptophan to niacin in rats. Biosci Biotechnol Biochem. 1995;59:2127-9.
19. Shibata K, Kondo T, Marugami M, Umezawa C. Increased conversion of tryptophan to niacin by the administration to clofibrate, a hypolipidemic drug, in rats. Biosci Biotechnol Biochem. 1996;60:1455-9.
20. Shibata K, Ishikawa A, Kondo T. Effect of dietary pyrazinamide on the metabolism of tryptophan to niacin in streptozotocin-diabetic rats. Biosci Biotechnol Biochem. 1997;61:1679-83.
21. Shibata K, Fukuwatari T, Enomoto A, Sugimoto E. Increased conversion ratio of tryptophan to niacin by dietary di-n-butylphthalate. J Nutr Sci Vitaminol (Tokyo). 2001;47:263-6.
22. Shibata K, Fukuwatari T, Sugimoto E. Effect of dietary pyrazinamide, an antituberculosis agent, on the metabolism of tryptophan to niacin and tryptophan to serotonin in rats. Biosci Biotechnol Biochem. 2001;65:1339-46.
23. Fukuwatari T, Suzuki Y, Sugimoto E, Shibata K. Elucidation of the toxic mechanism of plasticizers, phthalic acid esters, putative endocrine disrupters: effects of dietary di(2-ethylhexyl)phthalate on the metabolism of tryptophan to niacin in rats. Biosci Biotechnol Biochem. 2002;66:705-10.
24. Fukuwatari T, Sugimoto E, Shibata K. Growth promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of an ACMSD activity. Biosci Biotechnol Biochem. 2002;66:1435-41.
25. Fukuwatari T, Suzuki Y, Sugimoto E, Shibata K. Identification of toxic mechanism of plasticizers, phthalic acid esters, which is a putative endocrine disrupters: time-dependent increase in quinolinic acid and its metabolites in rats fed di(2-ethylhexyl)phthalate diet. Biosci Biotechnol Biochem. 2002;66:2687-91.
26. Fukuwatari T, Ohsaki S, Fukuoka S, Sasaki R, Shibata K. Phthalate esters enhance quinolinate production by inhibiting a-amino-b-carboxymuconate-e-semialdehyde decarboxylase (ACMSD), a key enzyme of the tryptophan pathway. Toxicol Sci. 2004;81:302-8.
27. Ghafoorunissa, Narasinga Rao BS. Effect of protein level in the diet on quinolinate phosphoribosyltransferase of rat liver. Life Sci. 1974;15: 1597-602.
28. Satyanarayana U, Narasinga Rao BS. Effect of diet restriction on some key enzymes on the tryptophan-NAD pathway in rats. J Nutr. 1977; 107:2213-8.
29. Rader JI, Calvert RJ, Hthcock JN. Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med. 1992;92:77-81.
30. Winter SL, Boyer JL. Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med. 1973;289:1180-2.
31. McKenney LM, Proctor JD, Harris S, Chinchili VM. A comparison of the efficacy and toxic effects of sustained-vs immediate-release niacin in hypercholesterolemic patients. JAMA. 1994;271-672-7.
32. Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava G, Gragnoli C, Andreani D, et al. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia. 1995;38:848-52.
33. Shibata K, Onodera M, Shimada S, Yasuda K. Changes in nicotinamide metabolism and its bioavailability during long-term administration of a multivitamin preparations. Vitamins. 1992;66:309-14.
34. Shibata K, Matsuo H. Effect of dietary tryptophan levels on the urinary excretion of nicotinamide and its metabolites in rats fed a niacin-free diet or a constant total protein level. J Nutr. 1990;120:1191-7.
35. Kimura N, Fukuwatari T, Sasaki R, Shibata K. The necessity of niacin in rats fed on a high protein diet. Biosci Biotechnol Biochem. 2005;69: 273-9.